Disc Medicine Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 32.24, 142.22, 338.83, 581.39 ], "ebit_estimate": [ -300.27, -331.62, -267.22, -142.86, 46.46 ], "ebitda_estimate": [ -293.97, -336.08, -342.97, null, null ], "net_income_estimate": [ -280.15, -320.71, -270.79, -141.31, 49.37 ], "per_share_eps_estimate": [ -7.21, -7.88, -6.11, -2.19, 1.22 ], "eps_nri_estimate": [ -7.15, -7.69, -6.19, -3.21, 1.22 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 12.31, 8.96, 9.01, null, null ], "pretax_income_estimate": [ -274.54, -312.53, -264.79, -163.33, 20.41 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -43.22, -62.45, -56.2, null, null ], "gross_margin_estimate": [ 82.95, 86.97, 86.93, 86.7, 86.8 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 62.78 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -13.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -23.19, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -18.72, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, 0.18, 4.26, 20.1 ], "ebit_estimate": [ -71.19, -74, -76.77, -75.43, -78.83, -74.1, -63.5 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -68.4, -71.94, -76.49, -80.33, -85.13, -83.33, -68.63 ], "per_share_eps_estimate": [ -1.77, -1.86, -1.92, -1.99, -2.1, -2.03, -1.69 ], "eps_nri_estimate": [ -1.75, -1.83, -1.9, -1.92, -1.99, -1.91, -1.63 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -66.8, -70.02, -74.34, -80.33, -85.13, -83.33, -68.63 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 78, 78, null, null, null, 87 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": -13.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -23.19, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -18.72, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }